Catherine Cheng is a CMC statistical lead at Novartis Gene Therapies. Her team provides technical expertise and statistical support from analytical development to commercialization. Prior to joining Novartis Gene Therapies, Catherine worked at Merck, BMS and Eli Lilly from 2001 to 2020. Catherine holds a BS in Chemical Engineering and MS in Statistics and Engineering.